FIELD: pharmacology; veterinary medicine.
SUBSTANCE: invention relates to the field of pharmacology and veterinary medicine and describes interpolymer polyelectrolyte complexes of a cationic polymer – polyalkylcarboxylic (polyacrylic or polymethacrylic) acid with anionic copolymer – N-vinylpyrrolidone and 2-methyl-5-vinylpyridine or 4-vinylpyridine or 2-vinylpyridine. Interpolymer polyelectrolyte complexes are biodegradable and are capable of destruction as a result of gradual destruction by the action of electrolytes and enzymatic systems present in the body of humans and animals.
EFFECT: prolonged medicinal and veterinary agents based on the above interpolymer polyelectrolyte complexes can be used as carriers of chemotherapeutic agents or basis for implants formed in situ.
6 cl, 1 dwg, 4 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
INTERPOLYMER POLYELECTROLYTE COMPLEX AND A PROLONGED IMMUNOSTIMULATING AGENT ON ITS BASIS, FOR MEDICAL AND VETERINARY USE | 2017 |
|
RU2683947C1 |
POLYMERIC MATERIAL OF MEDICAL PURPOSE FOR EMBOLIZATION | 2017 |
|
RU2669801C1 |
INTERPOLYMER CARRIER FOR ORAL SYSTEMS OF CONTROLLED DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS | 2018 |
|
RU2725879C2 |
IMPLANTED DRUG PREPARATION OF NALTREXONE FOR TREATING ALCOHOL- OR OPIOID-DEPENDENT PATIENTS | 2012 |
|
RU2476209C1 |
COPOLYMER HAVING ACTIVITY AGAINST INFLUENZA TYPE A (VERSIONS), CONTAINING UNITS OF N-VINYLPYRROLIDONE AND OPTIONALLY C-METHYLATED VINYLPYRIDINE, COMPLETELY METHYL QUATERNIZED WITH METHYL IODIDE | 2023 |
|
RU2827336C1 |
COPOLYMER CONTAINING UNITS OF N-VINYLPYRROLIDONE AND OPTIONALLY C-METHYLATED VINYLPYRIDINE, PARTIALLY METHYLQUATERNISED WITH METHYL IODIDE, HAVING ANTI-INFLUENZA ACTIVITY (VERSIONS) | 2023 |
|
RU2827701C1 |
N-VINYLPYRROLIDONE-BASED COPOLYMERS IN FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS OF ACIDS | 2013 |
|
RU2533113C1 |
SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2643329C1 |
ANTIINFLAMMATORY COMPOSITION OF PROLONGED ACTION BASED ON SODIUM DICLOFENAC AND METHOD OF ITS PREPARING | 1992 |
|
RU2070034C1 |
SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2635517C1 |
Authors
Dates
2019-04-10—Published
2017-07-14—Filed